You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HPV vaccination in healthy females

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Papillomavirus Vaccine Trial in Banjul (9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses, 9-valent human

Active, not recruiting
  • Human Papillomavirus Vaccine
  • 9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses
  • +2 more
  • Banjul, Outside U.S. And Canada, Gambia
    Ed Clarke
Mar 15, 2022

Cervical Intraepithelial Neoplasia Trial (HPV9 High formulation, HPV9 Medium formulation, HPV9 Low formulation)

Not yet recruiting
  • Cervical Intraepithelial Neoplasia
  • HPV9 High formulation
  • +3 more
  • (no location specified)
Aug 10, 2022

Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Yangchun (4-valent HPV Vaccine, 9-valent HPV Vaccine, GARDASIL®)

Completed
  • Cervical Cancer
  • +13 more
  • 4-valent HPV Vaccine
  • +2 more
  • Yangchun, Guangdong, China
    Yangchun Center For Disease Prevention And Control
Feb 23, 2022

Cervical Cancer, Genital Wart, CIN1 Trial (Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine

Not yet recruiting
  • Cervical Cancer
  • +11 more
  • Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha)
  • Placebo
  • (no location specified)
Oct 17, 2022

HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Guangxi (Experimental: Experimental: 9-valent Human Papillomavirus

Completed
  • HPV Infections
  • +14 more
  • Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
  • Active Comparator: GARDASIL ®9
  • Guangxi, China
    Guangxi Zhuang Autonomous Region Center for Disease Control and
May 9, 2022

HPV Trial (Vaccination with PANHPVAX 10µg, Vaccination with PANHPVAX 40µg, Vaccination with PANHPVAX 100µg)

Not yet recruiting
  • HPV
  • Vaccination with PANHPVAX 10µg
  • +2 more
  • (no location specified)
Jun 1, 2022

After Whole Vaccination Shcedule With Recombination Quadrivalent

Not yet recruiting
  • HPV Infections
  • +6 more
    • (no location specified)
    May 7, 2022

    HPV Infection Trial in Mianyang (Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris))

    Active, not recruiting
    • HPV Infection
    • Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris)
    • Mianyang, Sichuan, China
      Mianyang Center for Disease Control and Prevention
    Jul 7, 2021

    Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Rongan County (9-valent Human Papillomavirus (Types 6, 11, 16,

    Recruiting
    • Cervical Cancer
    • +13 more
    • 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha)
    • GARDASIL®
    • Rongan County, Guangxi Zhuang Autonomous Region, China
      Rongan County Center for Disease Control and Prevention
    Feb 20, 2022

    Papillomavirus Vaccines Trial in Rochester (Current care, Reminder-recall, Audit-and-feedback)

    Recruiting
    • Papillomavirus Vaccines
    • Current care
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic
    Jul 28, 2022

    Two Domestic HPV Vaccines and Imported HPV Vaccines in Women

    Not yet recruiting
    • HPV Infection
    • +2 more
    • Follow up
    • Fuzhou, Fujian, China
      Fujian Maternity and Child Health Hospital
    Nov 16, 2023

    Human Papilloma Virus, Preventable Disease, Vaccine, Health Knowledge, Attitudes, Practice Trial in Phoenix (Baseline Surveys,

    Completed
    • Human Papilloma Virus
    • +3 more
    • Baseline Surveys
    • Digital Storytelling Intervention
    • Phoenix, Arizona
      Arizona State University
    Apr 26, 2023

    Human Immunodeficiency Virus, Human Papillomavirus- 6, 11, 16, 18, Adolescent Trial run by the NCI (Gardasil, Survey)

    Completed
    • Human Immunodeficiency Virus
    • +3 more
    • Gardasil
    • Survey
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 26, 2022

    Cervical Cancer, Condylomata Acuminata Trial in Nanjing (Recombinant Human Papillomavirus Nonavalent (Types

    Active, not recruiting
    • Cervical Cancer
    • Condylomata Acuminata
    • Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli)
    • Gardasil®9
    • Nanjing, Jiangsu, China
      Jiangsu Provincial Centre for Disease Control and Prevention
    Feb 10, 2022

    Human Papillomavirus Viruses, Papillomavirus Vaccines Trial in Cincinnati (K-Talk Intervention (Storytelling and K-Bot),

    Recruiting
    • Human Papillomavirus Viruses
    • Papillomavirus Vaccines
    • K-Talk Intervention (Storytelling and K-Bot)
    • +3 more
    • Cincinnati, Ohio
      Minjin Kim
    May 31, 2023

    Human Papillomavirus Infection Trial in Kunming (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

    Active, not recruiting
    • Human Papillomavirus Infection
    • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
    • GARDASIL® 9
    • Kunming, Yunnan, China
      Yunnan Center for Disease Prevention and Control
    Dec 23, 2022

    Immunization, Efficacy, Human Papilloma Virus Trial in Galveston (9-valent HPV vaccine, 2 dose efficacy, 9-valent HPV vaccine, 3

    Recruiting
    • Immunization
    • +2 more
    • 9-valent HPV vaccine, 2 dose efficacy
    • 9-valent HPV vaccine, 3 doses standard timing
    • Galveston, Texas
      University of Texas Medical Branch
    Jan 30, 2023

    Papillomavirus Infections Trial in Quzhou, Shaoxing (V503)

    Active, not recruiting
    • Papillomavirus Infections
    • V503
    • Quzhou, Zhejiang, China
    • +1 more
    Aug 17, 2022

    Immunization, HPV Infection, Human Papillomavirus Trial in Galveston (9-valent HPV vaccine, 2 doses alternate timing, 9-valent

    Recruiting
    • Immunization
    • +2 more
    • 9-valent HPV vaccine, 2 doses alternate timing
    • 9-valent HPV vaccine, 3 doses standard timing
    • Galveston, Texas
      University of Texas Medical Branch
    Jan 30, 2023

    Human Papillomavirus-Related Carcinoma Trial in Austria, United States (procedure, biological, other)

    Not yet recruiting
    • Human Papillomavirus-Related Carcinoma
    • Biospecimen Collection
    • +4 more
    • Birmingham, Alabama
    • +4 more
    Aug 9, 2023

    Cancer Trial in United States (4 Corners Rural Health Cancer Prevention)

    Not yet recruiting
    • Cancer
    • 4 Corners Rural Health Cancer Prevention
    • Tucson, Arizona
    • +4 more
    Nov 8, 2022

    HPV Infections, Cervical Cancer Stage IIa, Vaginal Cancer Trial in Mianyang (2-doses Group among 9-14 years, 3-doses Group among

    Recruiting
    • HPV Infections
    • +6 more
    • 2-doses Group among 9-14 years
    • +2 more
    • Mianyang, Sichuan, China
      Center for Disease Control and Prevention
    Feb 23, 2022

    Late Complication From Kidney Transplant, Complication of Transplanted Liver, Human Papillomavirus-Related Carcinoma Trial in

    Completed
    • Late Complication From Kidney Transplant
    • +2 more
    • Quadravalent human papillomavirus vaccine
    • Toronto, Ontario, Canada
      The Hospital for Sick Children
    Feb 10, 2021

    HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Hangzhou (9-valent HPV vaccine)

    Recruiting
    • HPV Infections
    • +14 more
    • 9-valent HPV vaccine
    • Hangzhou, China
      Huakun Lv
    Feb 23, 2022

    Human Papillomavirus Infection Trial in Canberra (Human papillomavirus (HPV) Vaccine, Placebo)

    Not yet recruiting
    • Human Papillomavirus Infection
    • Human papillomavirus (HPV) Vaccine
    • Placebo
    • Canberra, Australia
      Paratus Clinical Research Canberra
    Jan 4, 2023